Randall Owen
Clinical Development
Acadia Pharmaceuticals
United States of America
Biography
Randall Owen M.D. is our Senior Vice President, Clinical Development and Chief Medical Officer and has been with ACADIA since January 2016. Dr. Owen most recently served as Vice President, U.S. Clinical Affairs at Lundbeck LLC from 2010 to 2016. During his tenure, he led a team of medical experts and scientists that developed drugs across a wide range of neurological and psychiatric disorders, including innovative development programs in schizophrenia, Alzheimer’s disease and stroke. Prior to joining Lundbeck, Dr. Owen served as Group Director, Global Clinical Research at Bristol-Myers Squibb Company where he co-led the life-cycle management of Abilify® during a period of product extensions in psychiatric indications in the United States and Europe. Dr. Owen received his B.A. at Haverford College and his M.D. at East Tennessee State University, Quillen College of Medicine. He completed his residency at Emory University and is board certified in psychiatry.
Research Interest
psychiatry.